Agnes B. Jousset
Fontenay-sous-bois, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Carbapenemase-producing Klebsiella oxytoca complex in France (2017-2023): Molecular epidemiology integrated with virulence and biofilm phenotypes.
Journal: Emerging microbes & infections
Published: August 03, 2026
Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".
Journal: Antimicrobial agents and chemotherapy
Published: June 24, 2026
Spread of carbapenemase-producing Serratia spp. in France from 2016 to 2024: a comparative genomic study.
Journal: Emerging microbes & infections
Published: May 07, 2026
Comparative evaluation of disc diffusion, Liofilchem™ MTS strips, Etest® Biomérieux with broth microdilution for eravacylin susceptibility testing.
Journal: The Journal of antimicrobial chemotherapy
Published: April 08, 2026
Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.
Journal: The Journal of antimicrobial chemotherapy
Published: February 20, 2026
In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.
Journal: Antimicrobial agents and chemotherapy
Published: February 12, 2026
Direct carbapenemase typing from disc diffusion antibiograms with MALCA (MAchine Learning CArbapenemase).
Journal: Nature communications
Published: January 07, 2026
Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.
Journal: Clinical microbiology reviews
Published: August 01, 2025
In vitro susceptibility of cefepime-enmetazobactam, cefepime-taniborbactam and cefepime-zidebactam towards carbapenemase-producing Enterobacterales.
Journal: The Journal of antimicrobial chemotherapy
Published: July 11, 2025
Therapeutic challenges in treating ESBL- and/or AmpC-producing non-carbapenemase-producing Enterobacterales: an in vitro evaluation of novel β-lactam/β-lactamase inhibitor combinations and cefiderocol.
Journal: The Journal of antimicrobial chemotherapy
Published: June 12, 2025
Characterization of Carbapenemase-producing Enterobacterales isolated from patients returning from Sub-Saharan Africa, France, 2015-2022.
Journal: The Journal of antimicrobial chemotherapy
Published: March 26, 2025
Last Updated: 09/26/2026